New data for KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
Development of Anti-inflammatory Bispecific Trap-antibodies
By
X
1250 Page Mill Road Palo Alto, CA 94304 United States of America